Liver Fibrosis and Steatosis in Inflammatory Bowel Disease: A Cross‐Sectional Matched‐Control Transient Elastography Study (ELASTIBD)
Besim Fazil Agargün, İbrahim Volkan Şenkal, Aynura Rustamzada, Kanan Nuriyev et autres
AIM: Metabolic dysfunction-associated steatotic liver disease (MASLD) and liver fibrosis are emerging extraintestinal manifestations of inflammatory bowel disease (IBD), but their true burden and the impact of therapies on liver health have not been fully elucidated. We aimed to assess the prevalence …
tr (code pays fourni par la source)
2 citations
Hepatology Research